Home Other Building Blocks 2-Butenedioic acid, 2-ethyl-, (2Z)-

2-Butenedioic acid, 2-ethyl-, (2Z)-

CAS No.:
13074-60-7
Catalog Number:
AG000UW5
Molecular Formula:
C6H8O4
Molecular Weight:
144.1253
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
Product Description
Catalog Number:
AG000UW5
Chemical Name:
2-Butenedioic acid, 2-ethyl-, (2Z)-
CAS Number:
13074-60-7
Molecular Formula:
C6H8O4
Molecular Weight:
144.1253
IUPAC Name:
2-ethylbut-2-enedioic acid
InChI:
InChI=1S/C6H8O4/c1-2-4(6(9)10)3-5(7)8/h3H,2H2,1H3,(H,7,8)(H,9,10)
InChI Key:
SASYHUDIOGGZCN-UHFFFAOYSA-N
SMILES:
CC/C(=C/C(=O)O)/C(=O)O
Properties
Complexity:
180  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
144.042g/mol
Formal Charge:
0
Heavy Atom Count:
10  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
144.126g/mol
Monoisotopic Mass:
144.042g/mol
Rotatable Bond Count:
3  
Topological Polar Surface Area:
74.6A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
1  
XLogP3:
0.4  
Literature
Title Journal
Characterization of a thermostable methylaspartate ammonia lyase from Carboxydothermus hydrogenoformans. Applied microbiology and biotechnology 20120401
Pharmacokinetics of anti-psoriatic fumaric acid esters in psoriasis patients. Archives of dermatological research 20100901
Fumaric acid dialkyl esters deprive cultured rat oligodendroglial cells of glutathione and upregulate the expression of heme oxygenase 1. Neuroscience letters 20100507
Fumarase: a mitochondrial metabolic enzyme and a cytosolic/nuclear component of the DNA damage response. PLoS biology 20100301
Cut and paste: a novel method of re-attaching rectus muscles with cyanoacrylate during recessions in strabismus. Indian journal of ophthalmology 20100101
Fumaric Acid and its esters: an emerging treatment for multiple sclerosis. Current neuropharmacology 20090301
Fumaric acid and its derivatives in the treatment of psoriasis vulgaris: our experience in forty-one patients. Acta dermatovenerologica Croatica : ADC 20090101
Fumaric acid esters. Clinics in dermatology 20080101
Dimethylfumarate induces immunosuppression via glutathione depletion and subsequent induction of heme oxygenase 1. The Journal of investigative dermatology 20070401
Use of fumaric acid esters in psoriasis. Indian journal of dermatology, venereology and leprology 20070101
BG 12: BG 00012, BG 12/Oral Fumarate, FAG-201, second-generation fumarate derivative--Fumapharm/Biogen Idec. Drugs in R&D 20050101
Pharmacokinetics of oral fumarates in healthy subjects. British journal of clinical pharmacology 20041001
In vitro pharmacokinetics of anti-psoriatic fumaric acid esters. BMC pharmacology 20040101
Presystemic metabolism and intestinal absorption of antipsoriatic fumaric acid esters. Biopharmaceutics & drug disposition 20030901
Plausible molecular mechanism for activation by fumarate and electron transfer of the dopamine beta-mono-oxygenase reaction. The Biochemical journal 20021001
Treatment of disseminated granuloma annulare with fumaric acid esters. BMC dermatology 20020101
Successful treatment of recalcitrant cutaneous sarcoidosis with fumaric acid esters. BMC dermatology 20020101
Properties